Essity

Transaction in Own Shares • Aug 25, 2025

Press release

Stockholm, August 25, 2025

Buyback of Class B shares in Essity during week 34, 2025

Between August 18, 2025, and August 22, 2025, Essity Aktiebolag (publ) repurchased a total of 390,489 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission's Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation.

Date	Aggregated daily volume (no. of shares):	Weighted average price per day (SEK):	Total daily transaction value (SEK):
August 18, 2025	71,907	249.5473	17,944,198
August 19, 2025	72,534	251.4808	18,240,908
August 20, 2025	80,584	254.4406	20,503,841
August 21, 2025	82,810	254.0099	21,034,560
August 22, 2025	82,654	255.3772	21,107,947
Total accumulated during week 34 2025	390,489	253.0966	98,831,454
Total accumulated during the buyback program	5,349,448	260.9014	1,395,678,258

Class B shares in Essity were repurchased as follows:

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity's holding of treasury shares amounted on August 22, 2025, to 6,131,948 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 58,973,654 Class A shares and 634,080,835 Class B shares.

For additional information, please contact:

Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

About Essity

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.